Unknown PHASE4 INTERVENTIONAL 1-arm NCT01636895

Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria (OR1)

An Evaluation of Sulfadoxine-pyrimethamine Resistance and Effectiveness of IPTp in Nigeria

Sponsor: Department for International Development, United Kingdom

Conditions Pregnancy Complications Parasitic

Interventions Efficacy of suphladoxine/pyrimethamine as IPTp

Updated 6 times since 2017 Last updated: Aug 21, 2012 Started: Jan 31, 2011 Primary completion: Nov 30, 2012 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01636895, this PHASE4 trial focuses on Pregnancy Complications Parasitic and remains ongoing. Sponsored by Department for International Development, United Kingdom, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Department for International Development, United Kingdom
London School of Hygiene and Tropical Medicine
Malaria Consortium, UK
University of Nigeria, Enugu Campus

Data source: Malaria Consortium, UK

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Enugu, Nigeria